Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

67.22
-1.7200-2.49%
Post-market: 67.370.1500+0.22%16:03 EDT
Volume:7.22M
Turnover:488.74M
Market Cap:298.39B
PE:19.76
High:69.49
Open:69.49
Low:66.71
Close:68.94
Loading ...

Novo Nordisk’s Promising Phase 3 Study on Sickle Cell Disease Treatment

TIPRANKS
·
4 hours ago

Novo Nordisk’s Diabetes Study: A New Era in Blood Sugar Management

TIPRANKS
·
4 hours ago

Novo Nordisk’s Mim8 Study: A Potential Game-Changer for Haemophilia A Treatment

TIPRANKS
·
4 hours ago

Berenberg Bank Remains a Hold on Novo Nordisk (0QIU)

TIPRANKS
·
Yesterday

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Yesterday

Clever Culture Says Novo Nordisk to Assess Its APAS Technology for Use Across Manufacturing Network

MT Newswires Live
·
14 Jul

Clever Culture Systems Secures Instrument Sale to Novo Nordisk for Evaluation

TIPRANKS
·
14 Jul

Novo Nordisk’s New Insulin Icodec: A Game Changer in Diabetes Management?

TIPRANKS
·
12 Jul

Market Chatter: FDA May Fast Track Drug Reviews for Lower US Prices

MT Newswires Live
·
11 Jul

Novo Nordisk (0QIU) Receives a Buy from UBS

TIPRANKS
·
11 Jul

Smart Money Going in Senior Health: Key Stocks in Elderly Care

Zacks
·
11 Jul

Novo Nordisk A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
11 Jul

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly

Motley Fool
·
10 Jul

Novo Nordisk’s Semaglutide Study: A Boost for Diabetes and PAD Treatment?

TIPRANKS
·
10 Jul

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Zacks
·
09 Jul

Pharma Companies Would Be Severely Hurt by 200% Tariff -- Market Talk

Dow Jones
·
09 Jul

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck

GlobeNewswire
·
09 Jul

Deutsche Bank Remains a Buy on Novo Nordisk (0QIU)

TIPRANKS
·
09 Jul

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

Dow Jones
·
09 Jul

Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs

MT Newswires Live
·
09 Jul